AdvaStim’s novel hardware and software platform gives developers capabilities to address current and emerging clinical indications. BEVERLY, Mass., April 23, 2014, AdvaStim, Inc., www.advastim.com, a leading developer of advanced technology platforms for neuromodulation therapies, announced today that the Company has entered the research and development market with a new hardware/software solution for neuromodulation therapy developers.Read more